Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death

Biophysical Journal

Volumn 97, Issue 2, 2009, Pages 415-434

  Zhang, Tongli ^a   Brazhnik, Paul ^a   Tyson, John J ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; CASPASE; CYTOCHROME C; DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE; PHOSPHATASE; PROTEIN BAX; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

AMPLIFIER; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL FATE; COMPUTER SIMULATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; HELPER CELL; KILLER CELL; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; POSITIVE FEEDBACK;

EID: 68949136900     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2009.04.053     Document Type: Article

References (74)

1. Johnstone, R. W., A. A. Ruefli, and S. W. Lowe. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153-164.
2. Fulda, S., and K. M. Debatin. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 25:4798-4811.
3. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell. 100:57-70.
4. Weinberg, R. A. 2007. The Biology of Cancer. Garland Science, New York.
5. Green, D. R. 2000. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:1-4.
6. Meng, X. W., S. H. Lee, and S. H. Kaufmann. 2006. Apoptosis in the treatment of cancer: a promise kept? Curr. Opin. Cell Biol. 18:668-676.
7. Albeck, J. G., J. M. Burke, B. B. Aldridge, M. Zhang, D. A. Lauffenburger, et al. 2008. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell. 30:11-25.
8. Rehm, M., H. Dussmann, R. U. Janicke, J. M. Tavare, D. Kogel, et al. 2002. Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J. Biol. Chem. 277:24506-24514.
9. Aldridge, B. B., G. Haller, P. K. Sorger, and D. A. Lauffenburger. 2006. Direct Lyapunov exponent analysis enables parametric study of transient signalling governing cell behaviour. IEE Syst. Biol. 153:425-432.
10. Bagci, E. Z., Y. Vodovotz, T. R. Billiar, G. B. Ermentrout, and I. Bahar. 2006. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys. J. 90:1546-1559.
11. Bentele, M., I. Lavrik, M. Ulrich, S. Stosser, D. W. Heermann, et al. 2004. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J. Cell Biol. 166:839-851.
12. Chen, C., J. Cui, H. Lu, R. Wang, S. Zhang, et al. 2007. Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. Biophys. J. 92:4304-4315.
13. Cui, J., C. Chen, H. Lu, T. Sun, and P. Shen. 2008. Two independent positive feedbacks and bistability in the bcl-2 apoptotic switch. PLoS ONE. 3:e1469.
14. Eissing, T., H. Conzelmann, E. D. Gilles, F. Allgower, E. Bullinger, et al. 2004. Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem. 279:36892-36897.
15. Fussenegger, M., J. E. Bailey, and J. Varner. 2000. A mathematical model of caspase function in apoptosis. Nat. Biotechnol. 18:768-774.
16. Hua, F., M. G. Cornejo, M. H. Cardone, C. L. Stokes, and D. A. Lauffenburger. 2005. Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 175:985-995.
17. Legewie, S., N. Bluthgen, and H. Herzel. 2006. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput. Biol. 2:e120.
18. Rehm, M., H. J. Huber, H. Dussmann, and J. H. Prehn. 2006. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J. 25:4338-4349.
19. Albeck, J. G., J. M. Burke, S. L. Spencer, D. A. Lauffenburger, and P. K. Sorger. 2008. Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol. 6:2831-2852.
20. Elledge, R. M., and W. H. Lee. 1995. Life and death by p53. Bioessays. 17:923-930.
21. Lu, X. 2005. p53: a heavily dictated dictator of life and death. Curr. Opin. Genet. Dev. 15:27-33.
22. Michalak, E., A. Villunger, M. Erlacher, and A. Strasser. 2005. Death squads enlisted by the tumour suppressor p53. Biochem. Biophys. Res. Commun. 331:786-798.
23. Chipuk, J. E., and D. R. Green. 2006. Dissecting p53-dependent apoptosis. Cell Death Differ. 13:994-1002.
24. Desagher, S., A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, et al. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:891-901.
25. Eskes, R., S. Desagher, B. Antonsson, and J. C. Martinou. 2000. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20:929-935.
26. Marani, M., T. Tenev, D. Hancock, J. Downward, and N. R. Lemoine. 2002. Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol. Cell. Biol. 22:3577-3589.
27. Chipuk, J. E., L. Bouchier-Hayes, and D. R. Green. 2006. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ. 13:1396-1402.
28. Green, D. R. 2005. Apoptotic pathways: ten minutes to dead. Cell. 121:671-674.
29. Riedl, S. J., and Y. Shi. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5:897-907.
30. Holcik, M., and R. G. Korneluk. 2001. XIAP, the guardian angel. Nat. Rev. Mol. Cell Biol. 2:550-556.
31. Cummins, J. M., M. Kohli, C. Rago, K. W. Kinzler, B. Vogelstein, et al. 2004. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64:3006-3008.
32. Lakhani, S. A., A. Masud, K. Kuida, G. A. Porter, Jr., C. J. Booth, et al. 2006. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 311:847-851.
33. Finucane, D. M., E. Bossy-Wetzel, N. J. Waterhouse, T. G. Cotter, and D. R. Green. 1999. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem. 274:2225-2233.
34. Murphy, K. M., V. Ranganathan, M. L. Farnsworth, M. Kavallaris, and R. B. Lock. 2000. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 7:102-111.
35. Shiozaki, E. N., J. Chai, and Y. Shi. 2002. Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc. Natl. Acad. Sci. USA. 99:4197-4202.
36. Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, and E. S. Alnemri. 1998. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:949-957.
37. Zou, H., R. Yang, J. Hao, J. Wang, C. Sun, et al. 2003. Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J. Biol. Chem. 278:8091-8098.
38. Suzuki, Y., Y. Nakabayashi, and R. Takahashi. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA. 98:8662-8667.
39. MacFarlane, M., W. Merrison, S. B. Bratton, and G. M. Cohen. 2002. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277:36611-36616.
40. Shiozaki, E. N., J. Chai, D. J. Rigotti, S. J. Riedl, P. Li, et al. 2003. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell. 11:519-527.
41. Sharpless, N. E., and R. A. DePinho. 2007. Cancer biology: gone but not forgotten. Nature. 445:606-607.
42. Harris, S. L., and A. J. Levine. 2005. The p53 pathway: positive and negative feedback loops. Oncogene. 24:2899-2908.
43. Mowat, M. R. 1998. p53 in tumor progression: life, death, and everything. Adv. Cancer Res. 74:25-48.
44. Oren, M. 2003. Decision making by p53: life, death and cancer. Cell Death Differ. 10:431-442.
45. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991.
46. Olsson, A., C. Manzl, A. Strasser, and A. Villunger. 2007. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ. 14:1561-1575.
47. Csikasz-Nagy, A., D. Battogtokh, K. C. Chen, B. Novak, and J. J. Tyson. 2006. Analysis of a generic model of eukaryotic cell-cycle regulation. Biophys. J. 90:4361-4379.
48. Zhang, T., P. Brazhnik, and J. J. Tyson. 2007. Exploring mechanisms of the DNA-damage response: p53 pulses and their possible relevance to apoptosis. Cell Cycle. 6:85-94.
49. Yu, J., and L. Zhang. 2003. No PUMA, no death: implications for p53-dependent apoptosis. Cancer Cell. 4:248-249.
50. Dynlacht, B. D. 2005. E2F and p53 make a nice couple: converging pathways in apoptosis. Cell Death Differ. 12:313-314.
51. Ginsberg, D. 2007. EGFR signaling inhibits E2F1-induced apoptosis in vivo: implications for cancer therapy. Sci. STKE. 2007:pe4.
52. Irwin, M., M. C. Marin, A. C. Phillips, R. S. Seelan, D. I. Smith, et al. 2000. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 407:645-648.
53. Braithwaite, A. W., G. Del Sal, and X. Lu. 2006. Some p53-binding proteins that can function as arbiters of life and death. Cell Death Differ. 13:984-993.
54. Furukawa, Y., N. Nishimura, Y. Furukawa, M. Satoh, H. Endo, et al. 2002. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem. 277:39760-39768.
55. Nahle, Z., J. Polakoff, R. V. Davuluri, M. E. McCurrach, M. D. Jacobson, et al. 2002. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4:859-864.
56. Bode, A. M., and Z. Dong. 2004. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer. 4:793-805.
57. Toledo, F., and G. M. Wahl. 2006. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat. Rev. Cancer. 6:909-923.
58. Aylon, Y., and M. Oren. 2007. Living with p53, dying of p53. Cell. 130:597-600.
59. Taira, N., K. Nihira, T. Yamaguchi, Y. Miki, and K. Yoshida. 2007. DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol. Cell. 25:725-738.
60. Brazhnik, P., and J. J. Tyson. 2006. Cell cycle control in bacteria and yeast: a case of convergent evolution? Cell Cycle. 5:522-529.
61. Chen, K. C., L. Calzone, A. Csikasz-Nagy, F. R. Cross, B. Novak, et al. 2004. Integrative analysis of cell cycle control in budding yeast. Mol. Biol. Cell. 15:3841-3862.
62. Eissing, T., F. Allgower, and E. Bullinger. 2005. Robustness properties of apoptosis models with respect to parameter variations and intrinsic noise. Syst. Biol. (Stevenage). 152:221-228.
63. Goldstein, J. C., N. J. Waterhouse, P. Juin, G. I. Evan, and D. R. Green. 2000. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2:156-162.
64. Chandra, D., J. W. Liu, and D. G. Tang. 2002. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J. Biol. Chem. 277:50842-50854.
65. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science. 281:1309-1312.
66. Martin, A. G., and H. O. Fearnhead. 2002. Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J. Biol. Chem. 277:50834-50841.
67. Willis, S. N., J. I. Fletcher, T. Kaufmann, M. F. van Delft, L. Chen, et al. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 315:856-859.
68. Harlin, H., S. B. Reffey, C. S. Duckett, T. Lindsten, and C. B. Thompson. 2001. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21:3604-3608.
69. Seoane, J., H. V. Le, and J. Massague. 2002. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 419:729-734.
70. Geva-Zatorsky, N., N. Rosenfeld, S. Itzkovitz, R. Milo, A. Sigal, E. Dekel, T. Yarnitzky, Y. Liron, P. Polak, G. Lahav, and U. Alon. 2006. Oscillations and variability in the p53 system. Mol. Syst. Biol. 2:2006.0033.
71. Hamstra, D. A., M. S. Bhojani, L. B. Griffin, B. Laxman, B. D. Ross, et al. 2006. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res. 66:7482-7489.
72. Ley, R., K. Balmanno, K. Hadfield, C. Weston, and S. J. Cook. 2003. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278:18811-18816.
73. Schuler, M., U. Maurer, J. C. Goldstein, F. Breitenbucher, S. Hoffarth, et al. 2003. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ. 10:451-460.
74. Smaili, S. S., Y. T. Hsu, K. M. Sanders, J. T. Russell, and R. J. Youle. 2001. Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ. 8:909-920.